T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.37% |
| 2 | Financials | 13.66% |
| 3 | Consumer Discretionary | 13.64% |
| 4 | Technology | 10.86% |
| 5 | Industrials | 10.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHK
1326
DELISTED
Chesapeake Energy Corporation
CHK
| $10.5M | ﹤0.01% |
4,716
-111
| -2% | -$313K |
|
|
SNMX
1327
DELISTED
Senomyx, Inc.
SNMX
| $10.5M | ﹤0.01% |
1,958,665
+400
| +0% | +$2.13K |
|
|
GAS
1328
DELISTED
AGL Resources Inc
GAS
| $10.4M | ﹤0.01% |
223,706
+700
| +0.3% | +$34.5K |
|
|
ADT
1329
DELISTED
ADT Corp
ADT
| $10.4M | ﹤0.01% |
310,231
+16,900
| +6% | +$644K |
|
1330
Royal Gold
RGLD
$19.7B
| $10.4M | ﹤0.01% |
168,896
-461,554
| -73% | -$29.6M |
|
|
AJRD
1331
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $10.4M | ﹤0.01% |
502,910
+76,300
| +18% | +$1.6M |
|
|
ARC
1332
DELISTED
ARC Document Solutions, Inc.
ARC
| $10.3M | ﹤0.01% |
1,359,558
-78,844
| -5% | -$642K |
|
1333
Nasdaq
NDAQ
$54.2B
| $10.3M | ﹤0.01% |
634,770
+68,400
| +12% | +$1.15M |
|
|
IBTX
1334
DELISTED
Independent Bank Group, Inc.
IBTX
| $10.3M | ﹤0.01% |
240,480
+43,870
| +22% | +$1.79M |
|
|
ECHO
1335
EchoStar
ECHO
$26.5B
| $10.3M | ﹤0.01% |
261,514
-864
| -0.3% | -$35.4K |
|
1336
Copa Holdings
CPA
$6.19B
| $10.3M | ﹤0.01% |
124,525
-14,225
| -10% | -$1.36M |
|
1337
Aspen Aerogels
ASPN
$491M
| $10.2M | ﹤0.01% |
1,533,630
+8,700
| +0.6% | +$59.5K |
|
1338
Transocean
RIG
$6.65B
| $10.1M | ﹤0.01% |
628,880
+5,335
| +0.9% | +$96.1K |
|
1339
Core Laboratories
CLB
$584M
| $9.99M | ﹤0.01% |
87,605
-23,300
| -21% | -$2.83M |
|
1340
TriplePoint Venture Growth BDC
TPVG
$221M
| $9.95M | ﹤0.01% |
738,397
+121,410
| +20% | +$1.69M |
|
|
ESV
1341
DELISTED
Ensco Rowan plc
ESV
| $9.93M | ﹤0.01% |
111,488
+2,015
| +2% | +$196K |
|
1342
Phibro Animal Health
PAHC
$1.4B
| $9.86M | ﹤0.01% |
253,200
+45,400
| +22% | +$1.57M |
|
1343
Avery Dennison
AVY
$13.5B
| $9.86M | ﹤0.01% |
161,711
+3,520
| +2% | +$205K |
|
1344
Designer Brands
DBI
$305M
| $9.66M | ﹤0.01% |
289,562
+42,000
| +17% | +$1.5M |
|
|
OPLN
1345
Openlane
OPLN
$4.39B
| $9.65M | ﹤0.01% |
681,625
+28,438
| +4% | +$407K |
|
|
RKT
1346
DELISTED
ROCK-TENN COMPANY CL-A
RKT
| $9.61M | ﹤0.01% |
159,547
-4,881
| -3% | -$308K |
|
|
HMHC
1347
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $9.6M | ﹤0.01% |
381,040
-1,110,100
| -74% | -$27.5M |
|
|
CPLA
1348
DELISTED
Capella Education Company
CPLA
| $9.5M | ﹤0.01% |
177,000
+7,200
| +4% | +$416K |
|
1349
OSI Systems
OSIS
$3.77B
| $9.5M | ﹤0.01% |
134,138
+130,200
| +3,306% | +$9.42M |
|
1350
NETSCOUT
NTCT
$2.88B
| $9.48M | ﹤0.01% |
258,500
-14,900
| -5% | -$612K |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.